Ophthalmoplegic migraine: inflammatory neuropathy with secondary migraine?

Can J Neurol Sci. 2007 Aug;34(3):349-55. doi: 10.1017/s0317167100006818.

Abstract

Background: This critical review provides a summary of the clinical presentation, neuroimaging, treatment and prognosis in pediatric ophthalmoplegic migraine (OM). The features of OM are not in keeping with its classification as a migraine-variant.

Method: We review 3 new and 37 reported pediatric OM cases.

Results: Headache was an inconsistent feature, with 25% patients showing no evidence of pain at the initial OM episode. Patients demonstrated: 1) prolonged time for symptom resolution to occur (median time 3 weeks); 2) tendency for recurrent episodes to have more severe and persistent nerve involvement; 3) evidence of permanent neurological sequelae with recurrent episodes (30% of patients); 4) rapid improvement and shortened duration with corticosteroid therapy and; 5) transient, reversible MRI contrast enhancement of the affected cranial nerve (86% of patients). These features would not be expected in primary migraine headache.

Conclusion: A detailed understanding of the natural history of OM is essential for the clinical. This review provides support that OM may result from cranial nerve inflammation with headache a secondary and later feature of this condition.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Age of Onset
  • Anti-Inflammatory Agents / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Male
  • Migraine Disorders / diagnosis
  • Migraine Disorders / etiology*
  • Migraine Disorders / physiopathology
  • Neuritis / complications*
  • Neuritis / diagnosis
  • Neuritis / physiopathology
  • Oculomotor Nerve / pathology
  • Oculomotor Nerve / physiopathology
  • Oculomotor Nerve Diseases / complications*
  • Oculomotor Nerve Diseases / diagnosis
  • Oculomotor Nerve Diseases / physiopathology
  • Ophthalmoplegia / complications*
  • Ophthalmoplegia / diagnosis
  • Ophthalmoplegia / physiopathology
  • Recurrence
  • Time Factors

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents